Connect With Us
Our team is ready to connect with you and learn more about your science.
Corporate Business Development
Search & Evaluation
| ||
|---|---|---|
|
Diabetes, Obesity, and Complications
| ||
|
Digital Health
|
Jim Koers (Clinical Capabilities)
| |
|
Genetic Medicines
|
Amanda Placone, PhD (Gene Therapy and Editing)
| |
|
Immunology
| ||
|
Molecule Innovation (Biologics)
| ||
|
Molecule Innovation (Discovery Chemistry)
|
Jim Koers (Novel Drug Development Methods)
| |
|
Neuroscience
|
Jenny Laird, PhD (Neurology and Pain)
|
Hallee Foster (Psychiatry)
|
|
Oncology
| ||
Adrienne Brown
Group VP, Head of Corporate Business Development
Transactions
| |
|---|---|
|
Head of Corporate Business Development Transactions and M&A
|
Jake Shuman
|
|
Diabetes, Obesity, and Complications
|
Tim Dolan
|
|
Genetic Medicines
|
Michael Johnson
|
|
Immunology
|
Vacant
|
|
International and Manufacturing
|
James A. (Andy) McGee
|
|
Neuroscience
|
Jeremy Fitch
|
|
Oncology
|
David Kutoloski
|
Alliance & Innovation Management
| |
|---|---|
|
Head of Alliance and Innovation Management
|
Wanda Rutledge-Gordon, PhD
|
|
Acquisitions
|
Kristi Huntington
|
|
Diabetes, Obesity, and Complications
|
Jamie McKenzie
|
|
Genetic Medicines, Neuroscience, Discovery/Chemistry/Research/Technology
|
Linda Kehn
|
|
Immunology, Oncology
|
Brent Harvey
|
|
International, Biotherapeutic Discovery Research
|
Lisa Keough
|
Lilly Catalyze360
Nisha Nanda, PhD
Group VP, Head of Lilly Catalyze360
Lilly Ventures
| |
|---|---|
|
Lilly Ventures Global Head
| |
|
Lilly Venture Science Global Head
| |
|
Lilly Venture Science Europe Hub
| |
|
Lilly Venture Science West Coast Hub
| |
|
Lilly Venture Science Asia Hub
|
Lilly Gateway Labs
| |
|---|---|
|
Contact Us
| |
|
Lilly Gateway Labs Global Head
|
Julie Gilmore, PhD
|
|
Lilly Gateway Labs Boston Hub
|
Vanessa Barth, PhD
|
|
Lilly Gateway Labs San Francisco Hub
|
Nina Kosaric, PhD
|
|
Lilly Gateway Labs San Diego Hub
|
Kathleen Lin, PhD
|
|
Lilly Gateway Labs Asia Hub
|
Shea McMurtry, PhD
|
Lilly ExploR&D
|
Contact
|
|---|---|
|
Lilly ExploR&D Head
|
Contact:
Tom Hopkins, MD, PhD
|
|
Lilly ExploR&D CMO
|
Contact:
Mona Kotecha, MD
|
|
Lilly ExploR&D Head of Clinical Program Management
|
Contact:
Daniel Mudra, PhD
|
|
Lilly ExploR&D External Partnering
|
Contact:
Pablo Cabral, MD, PhD
|
Lilly Catalyze360 Portfolio Management
| |
|---|---|
|
Lilly Catalyze360 Portfolio Management
|
Julie Gilmore, PhD
|
|
Lilly Catalyze360 Program Management
|
Lance Pfeifer, PhD
|
|
Lilly Catalyze360 Innovation
|
Tom Marron, PhD
|
|
Lilly Catalyze360 Artificial Intelligence/Machine Learning
|
Aliza Apple, PhD
|
Connect With Us
We are ready to hear more about your promising work and how we can help propel your scientific visions.
Corporate Business Development
We seek the most powerful science for strategic partnerships, licensing and potential acquisitions in our core therapeutic areas. Through Search & Evaluation, Transactions and Alliance & Innovation Management, we operate on the frontiers of medicine development.
Lilly Catalyze360
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.